{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:38:31Z","timestamp":1781239111854,"version":"3.54.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002037","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002037","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002037","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002037","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.thromres.2014.12.017","type":"journal-article","created":{"date-parts":[[2014,12,27]],"date-time":"2014-12-27T16:49:37Z","timestamp":1419698977000},"page":"479-484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Clinical use of Haemate\u00ae P in von Willebrand disease: A 25-year retrospective observational study"],"prefix":"10.1016","volume":"135","author":[{"given":"Wolfgang","family":"Miesbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Krekeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhard","family":"Seifried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2014.12.017_bb0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/10408360600966753","article-title":"The role of von Willebrand factor in hemorrhagic and thrombotic disorders","volume":"44","author":"Franchini","year":"2007","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.thromres.2014.12.017_bb0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1468-0734.2001.00048.x","article-title":"Von Willebrand factor and von Willebrand disease","volume":"5","author":"Budde","year":"2001","journal-title":"Rev Clin Exp Hematol"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2014.12.017_bb0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1538-7836.2011.04324.x","article-title":"von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein","volume":"9","author":"Schneppenheim","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.12.017_bb0020","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1055\/s-0031-1281028","article-title":"Von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder","volume":"37","author":"Favaloro","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2014.12.017_bb0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.12.017_bb0030","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.12.017_bb0035","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1517\/14712598.2012.667398","article-title":"Biological therapies for von Willebrand disease","volume":"12","author":"Favaloro","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.thromres.2014.12.017_bb0040","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.2165\/00003495-200767100-00010","article-title":"Human plasma von Willebrand factor\/factor VIII complex (Haemate P\/Humate-P) in von Willebrand disease and haemophilia A: a viewpoint by Eric Berntorp","volume":"67","author":"Berntorp","year":"2007","journal-title":"Drugs"},{"issue":"Suppl. 3","key":"10.1016\/j.thromres.2014.12.017_bb0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2516.1998.0040s3033.x","article-title":"Pharmacokinetics, efficacy and safety of Humate-P in von Willebrand disease","volume":"4","author":"Dobrkovska","year":"1998","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.12.017_bb0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1351-8216.2003.00809.x","article-title":"Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII\/VWF concentrate (Humate-P)","volume":"10","author":"Thompson","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.12.017_bb0055","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1351-8216.2003.00816.x","article-title":"Successful treatment of urgent bleeding in von Willebrand disease with factor VIII\/VWF concentrate (Humate-P): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy","volume":"9","author":"Gill","year":"2003","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.12.017_bb0060","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2516.2011.02534.x","article-title":"von Willebrand factor\/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease","volume":"17","author":"Gill","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.12.017_bb0065","first-page":"533","volume":"11","author":"Mannuccio Mannucci","year":"2013","journal-title":"Blood Transfus"},{"key":"10.1016\/j.thromres.2014.12.017_bb0070","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1160\/TH10-09-0616","article-title":"Long-term secondary prophylaxis in children, adolescents and young adults with von Willebrand disease. Results of a cohort study","volume":"105","author":"Halimeh","year":"2011","journal-title":"Thromb Haemost"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2014.12.017_bb0075","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.thromres.2006.01.021","article-title":"Clinical experience of prophylactic treatment in von Willebrand disease","volume":"118","author":"Lethagen","year":"2006","journal-title":"Thromb Res"},{"issue":"Suppl. 5","key":"10.1016\/j.thromres.2014.12.017_bb0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-2516.2008.01852.x","article-title":"Pathogen safety of plasma-derived products - Haemate P\/Humate-P","volume":"14","author":"Groner","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.12.017_bb0085","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1365-2516.2011.02603.x","article-title":"Repeated infusions of VWF\/FVIII concentrate: impact of VWF:FVIII ratio on FVIII trough and peak levels in a rabbit model","volume":"17","author":"Raquet","year":"2011","journal-title":"Haemophilia"},{"issue":"Suppl. 3","key":"10.1016\/j.thromres.2014.12.017_bb0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2516.1998.0040s3048.x","article-title":"Clinical management of patients with von Willebrand\u2019s disease with a VHP vWF concentrate: the French experience","volume":"4","author":"Goudemand","year":"1998","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.12.017_bb0095","series-title":"Querschnitts-Leitlinien (B\u00c4K) zur Therapie mit Blutkomponenten und Plasmaderivaten. 4. Auflage 2008","article-title":"Board of the German Medical Council on the recommendation of the Scientific Advisory Board","year":"2008"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814006860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814006860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T05:08:05Z","timestamp":1717650485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384814006860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0049384814006860"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2014.12.017","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical use of Haemate\u00ae P in von Willebrand disease: A 25-year retrospective observational study","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2014.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}